Conference call: Prenetics Global Sees Q4 Sales $73.000M-$83.000M vs $78.564M Est
Prenetics Global (NASDAQ:PRE) sees Q4 sales of $73.000 million-$83.000 million vs $78.564 million analyst estimate.
Follow the latest Prenetics Global Limited (PRE) news and market headlines alongside the live PRE price. Stay informed on what's moving PRE.
Prenetics Global (NASDAQ:PRE) sees Q4 sales of $73.000 million-$83.000 million vs $78.564 million analyst estimate.
U.S. stocks mostly fell, led by a 1.32% Dow drop. Target beat estimates and raised guidance; TJX and Bellring rallied, while oil and metals slid.
Gainers Akanda (NASDAQ:AKAN) shares rose 66.8% to $3.42 during Wednesday's regular session. The market value of their outstanding shares is at $5.4 million. Cue Biopharma (NASDAQ:CUE) shares rose 47.7% to $4.18.
U.S. stocks fell as the Dow slid 300+ points; Nvidia beat Q3 estimates, while energy, commodities and European markets declined.
Prenetics Global (NASDAQ:PRE) reported quarterly losses of $(1.43) per share which missed the analyst consensus estimate of $(0.72) by 98.61 percent. This is a 248.78 percent decrease over losses of $(0.41) per share
Prenetics Global (NASDAQ:PRE) affirms FY2026 sales outlook from $220.000 million-$230.000 million to $220.000 million-$230.000 million vs $224.204 million estimate.
News and data on this page is provided by our partnered third-party news and market data provider, with the original publisher credited on each article. All third-party content reflects the views of the original publisher and does not represent the views of MEXC. Price and market data shown on this page are provided by third-party data providers and may be delayed. MEXC offers trading products related to PRE, including RealStocks and Stock Futures.
The content on this page is provided for informational purposes only and does not constitute investment, financial, or trading advice. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of any news or market data shown. Trading U.S. stocks and related products involves significant risk, and prices can move sharply in a short period. Past performance does not guarantee future results. Please conduct your own research and assess your financial situation and risk tolerance before making any investment decisions. MEXC is not liable for any losses arising from the use of this information.